Stefan Christian Schneid

Title: The Innovations of Stefan Christian Schneid

Introduction

Stefan Christian Schneid is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of freeze-dried pellets comprising factor VIII. His innovative methods have the potential to enhance the stability and efficacy of important medical treatments.

Latest Patents

Stefan holds a patent for a "Method for the production of freeze-dried pellets comprising factor VIII." This method involves several steps, including freezing droplets of a solution containing factor VIII to form pellets and subsequently freeze-drying these pellets. The process utilizes a cooling tower with a temperature-controllable inner wall surface, ensuring that the interior temperature remains below the freezing point of the solution. The pellets are then freeze-dried in a rotating receptacle housed within a vacuum chamber. This innovative approach aims to improve the production efficiency and quality of factor VIII preparations.

Career Highlights

Stefan is associated with Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to focus on developing advanced methods for pharmaceutical production, contributing to the company's reputation for innovation in the healthcare sector.

Collaborations

Stefan has collaborated with esteemed colleagues such as Carsten Olbrich and Matthias Plitzko. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.

Conclusion

Stefan Christian Schneid's contributions to the field of pharmaceuticals, particularly through his patented methods for producing freeze-dried pellets, demonstrate his commitment to innovation and excellence. His work continues to impact the industry positively, paving the way for advancements in medical treatments.